Biograil

Roskilde, Denmark · Founded 2019 · Privately Held (backing)

Developer of a medical device designed to replace the standard injection system of medicines. Biograil is based in Roskilde, Denmark and was founded in 2019. Its last reported valuation was $31.5 million in Dec 2025. It has raised $21.1 million.

Last reported valuation
$31.5M
Oct 2026
Priced at
—
Total raised
$21.1M
Last round
—

Who backs Biograil?

11 investors
InvestorType
High-Tech GründerfondsVenture capital
Kinled HoldingFamily office
Verve VenturesVenture capital
Evonik Venture CapitalOther
Sanner VenturesFamily office
Acondis—
EIT Health—
Eli Lilly—
Lars Christiansen—
Megatrend Invest—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Biograil investors

11 investors are on record for Biograil, including High-Tech Gründerfonds, Kinled Holding, Verve Ventures and Evonik Venture Capital.

Free account
More of Biograil with a free account
  • ·The complete investor list: 11 names
  • ·Watch Biograil: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Biograil. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View